Coldstream Capital Management Inc Crispr Therapeutics Ag Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,122 shares of CRSP stock, worth $79,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,122Holding current value
$79,765% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
61.5MCall Options Held
2.15MPut Options Held
2.37M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$382 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$228 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$143 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$104 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$95.5 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.93B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....